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Purpose: We assessed the relationships between iron and vitamin D statuses in breastfed infants and 
their mothers and evaluated the determinants of iron and vitamin D deficiencies in breastfed infants.
Methods: Seventy breastfed infants aged 4–24 months and their mothers participated in this study 
from February 2012 to May 2013. Complete blood counts, total iron binding capacity, and levels of 
C-reactive protein, iron, ferritin, calcium, phosphate, alkaline phosphatase, and 25-hydroxyvitamin D 
(25(OH)D) in infants and their mothers were measured. 
Results: A history of maternal prepregnancy anemia was associated with lower ferritin and 25(OH)D 
levels in both infants and their mothers. The 25(OH)D level of infants correlated with maternal 25(OH)
D levels. The independent risk factors for iron deficiency in breastfed infants were the duration of 
breastfeeding (odds ratio [OR], 6.54; 95% confidence interval [CI], 1.09–39.2; P=0.04) and infant 
body weight (OR, 2.65; 95% CI, 1.07–6.56; P=0.04). The determinants for vitamin D deficiency were 
the infant’s age (OR, 0.15; 95% CI, 0.02–0.97; P=0.046) and maternal 25(OH)D level (OR, 0.74; 95% 
CI, 0.59–0.92; P=0.01).
Conclusion: A maternal history of prepregnancy anemia requiring iron therapy was associated with 
lower current ferritin and 25(OH)D levels in both infants and their mothers. Therefore, physicians 
should monitor not only iron but also vitamin D levels in infants who are breastfed by mothers who had 
prepregnancy anemia.
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Introduction 
There has been debate about the adequacy of the human milk for maintaining an ideal 
iron status and for providing other micronutrients in exclusively breastfed infants1). Given 
that maternal nutritional status affects the contents of breast milk, it can be hypothesized 
that the deficiency of iron and other nutrients in mothers may reduce the micronutrient 
stores in their infants. 
It has been reported that infants born to anemic mothers have low iron stores and are 
more likely to develop anemia2,3). The American Academy of Pediatrics’ (AAP) recom­
mendations indicate that supplementation of oral iron drops before 6 months to breastfed 
infants may be needed to support iron stores4). However, several studies have shown that 
there is little correlation between maternal and neonatal ferritin con centrations5,6), and that 
maternal anemia does not affect breast milk iron or lactoferrin concentration at birth and 
during early lactation7). 
Vitamin D stores in the fetus depend on maternal vitamin D status and breastfed infants 
continue to rely upon their mother’s nutritional status. Previous studies have reported a 
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high prevalence of Vitamin D deficiency (VDD) in breastfed 
infants8­10), and AAP recommended that all breastfed infants rou­
tinely should receive an oral supplement of vitamin D, 400 IU per 
day, beginning at hospital discharge to maintain an adequate 
serum vitamin D concentration11).
A concurrent deficit of micronutrients, including iron and vi ta­
min D, in breastfed infants may result in a wide spectrum of 
adverse effects on growth, development and performance12). How­
ever, the iron and vitamin D status of breastfed infants in relation 
to the status of their mothers has not yet been sufficiently 
evaluated. 
This retrospective study was performed to investigate the rela­
tionships between the iron and vitamin D status of breastfed 
infants and their mothers and to evaluate the risk factors for iron 
deficiency (ID) and VDD in breastfed infants. 
Materials and methods
Seventy breastfed infants aged 4 to 24 months and their 
mothers who visited Pediatric Department at the CHA Bundang 
Medical Center (Seongnam, Korea) were included in our study 
from February 2012 to May 2013. Exclusion criteria were (1) 
births at <35 weeks of gestation age or with low birth weight 
(≤2,500 g), (2) formula fed infants, and (3) mothers and infants 
who had taken micronutrient supplements including iron or 
vitamin D at enrollment.
Through the questionnaire, information about maternal history 
of pre­ or postpregnancy anemia requiring iron supplementation, 
the pattern of menstruation after childbirth, maternal history of 
additional iron supplementation both during pregnancy and after 
delivery, the birth­related history, the duration of breast feeding 
and the weaning pattern were retrospectively checked. Addi­
tionally, laboratory test including the complete blood count, re­
ticulocyte count, C­reactive protein (CRP), iron, total iron bind ing 
capacity, ferritin, calcium, phosphate, alkaline phosphatase, and 
25­hydroxyvitamin D (25(OH)D) levels were performed both in 
infants and mothers. CRP was measured by high­sensitivity me­
thods using an immunoturbidimetric assay. Serum ferritin was 
measured by chemiluminescence immunoassay. If the CRP level 
was greater than 0.3 mg/dL, we considered that serum ferritin had 
been affected by inflammation and as such excluded the ferritin 
data from statistical analysis (n=25). The serum 25(OH)D levels 
were measured by a radio immunoassay kit from DiaSorin (Still­
water, MN, USA). 
The infants were classified into iron deficiency anemia (IDA), 
ID, and normal groups. IDA was defined as hemoglobin (Hb)≤11 
g/dL and ferritin≤12 ng/mL. IDA in infants with a CRP of more 
than 0.3 mg/dL was diagnosed as Hb≤11 g/dL with a mean cor­
puscular volume<70 fL and a transferrin saturation<16% (n=16). 
ID was defined as Hb>11 g/dL and ferritin≤12 ng/13). The maternal 
iron status was defined as ID if ferritin<50 ng/mL14). VDD was 
defined as 25(OH)D≤20 ng/mL, and vitamin D insufficiency (VDI) 
as 25(OH)D of 20–30 ng/mL15). 
Data are expressed as means±standard deviations. The quan­
titative parameters of the groups were compared by t test. For 
comparing the 25(OH)D levels, we used analysis of variance to 
avoid interference by seasonal variation. Pearson correlation was 
performed to evaluate the relationship between the hematologic 
parameters and the 25(OH)D levels of infants and their mothers. 
Multivariable logistic regression was used to examine the influ­
ence of several variables on the iron and vitamin D status of 
breastfed infants. The PASW Statistics ver. 18.0 (SPSS Inc., 
Chicago, IL, USA) was used for the statistical analysis. A P value < 
0.05 and a confidence interval of 95% were considered statistically 
significant. This study was approved by the Institutional Review 
Board of the Medical Faculty at CHA University (BD 2014­0740).
Results
The demographic and clinical characteristics of our study parti­
cipants are shown in Table 1. The average birth weight was 3.2± 
0.4 kg. Eleven infants (16%) were born between 35 and 37 weeks 
of gestation, and no one before 35 weeks. The number of mothers 
with prepregnancy anemia was 21 (30%). The number of mothers 
who had taken additional iron supplements during pregnancy 
was 34 (49%).
Among 70 infants, 81% (n=57) had VDD. In terms of iron status, 
60% (n=42) in infants had IDA, 10% (n=7) had ID, and 30% (n=21) 
had normal. Infants with IDA and VDD were 53% (n=37). Among 
Table 1. Characteristics of the study participants (n=70)
Characteristic        Infants Mothers
Age (yr) 0.98±0.4 32.3±3.3
Male sex, n (%) 45 (64)
Duration of breast feeding (mo) 9.2±0.7
Body weight (kg) 9.0±1.5
Hemoglobin (g/dL) 10.3±1.6 13.1±1.0
MCV (fL) 70.3±7.1 87.3±4.3
RDW (%) 14.9±1.8 12.8±0.6
Calcium (mg/dL) 9.4±1.3 9.0±0.4
Phosphorus (mg/dL) 4.6±0.8 3.8±0.6
ALP (mg/dL) 649.8±376.6 230.1±79.7
Ferritin (ng/mL) 31.0±48.4 41.9±22.9
Transferrin saturation (%) 7
25(OH)D (ng/mL) 11.4±8.6 12.4±4.4
Values are presented as mean±standard deviation unless otherwise indicated. 
MCV, mean corpuscular volume; RDW, red blood cell distribution width; ALP, 
alkaline phosphatase; 25(OH)D, 25-hydroxyvitamin D. 
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mothers, 89% (n=62) had VDD and only 1% (n=1) had IDA. 
 Mothers with history of anemia before pregnancy had lower 
ferritin level than those without (P=0.034) (Table 2). The level of 
25(OH)D was significantly lower in infants and their mothers with 
history of prepregnancy anemia than in those without. There was 
no difference in ferritin and 25(OH)D levels of mothers and in­
fants according to the history of iron supplementation during 
pregnancy (data not shown).
The independent risk factors for ID or IDA in infants were body 
weight (P=0.04), and the duration of breast feeding (P=0.04) 
(Table 3).
The 25(OH)D levels of infants were significantly related with 
the maternal 25(OH)D levels (Fig. 1). By multivariable logistic 
regression, younger age and lower maternal vitamin D level were 
found to be independently associated with VDD (P=0.046 and 
P=0.01, respectively) (Table 4).
Discussion 
Our data show that a maternal prepregnancy history of anemia 
was associated with lower current ferritin and lower 25(OH)D in 
both infant and their mothers. The duration of breast feeding was 
the independent risk factors for ID. Maternal vitamin D levels 
significantly affected the level of vitamin D in their infants.
It was reported that deficiencies of vitamins, iron, and zinc 
occur concurrently in lactating mothers and their infants in rural 
villages in Indonesia16). In recent years, breast feeding has become 
more common in Korea. A recent epidemiologic survey in 2009 
showed that the overall breast feeding rate in Korea was 89.0% 
and the exclusive BMF rate at 6 months of age was 49.3%17). The 
concurrent VDD and IDA in infants have also been observed in 
recent Korean studies18,19).
In this study, ferritin in mothers with prepregnancy anemia was 
significantly lower than in those mothers without a history of 
anemia. Neither maternal anemia nor prepregnancy history of 
anemia was related with ID in their infants. Several studies have 
shown that there is little correlation between maternal and 
neonatal ferritin concentration5,16). No correlation between ma­
ternal and neonatal ferritin level may come from the fact that 
breast milk iron concentration is usually consistent in various 
ma ternal iron status7). In lactating rats with different iron status, 
mammary gland transferrin receptors were inversely related to 
iron status20). It can be hypothesized that an anemic woman 
would have a large number of transferrin receptors in her mam­
Table 2. Hemoglobin, ferritin, and 25-hydroxyvitamin D levels in mothers 
and their infants depending on the history of prepregnancy anemia
Variable History of anemia (n=21)
No history of anemia
(n=48) P value
Mothers
Hb (g/dL) 13.4±1.08 13.0±0.89 0.088
Ferritin (ng/mL) 33.4±10.59 45.8±25.89 0.034*
25(OH)D (ng/mL)† 11.1±3.18 13.0±4.78 0.033*
Infants
Hb (g/dL) 10.2±1.70 10.3±1.52 0.776
Ferritin(ng/mL) 17.2±18.13 28.3±56.71 0.398
25(OH)D(ng/mL)†   8.3±6.86 12.8±8.92 0.011*
Values are presented as mean±standard deviation.
Hb, hemoglobin; 25(OH)D, 25-hydroxyvitamin D.
*P<0.05. †Analysis of covariance to avoid interference in seasonal variation. 
Table 3. Determinants of iron deficiency in breastfed infants 
Variable Odds ratio (95% CI) 
Age (mo) 0.19 (0.04–1.02)
Birth weight (kg) 0.03* (0.002–0.34)
Body weight (kg) 2.65* (1.07–6.56)
Duration of breast feeding (mo) 6.54* (1.09–39.2)
History of prepregnancy anemia 1.15 (0.15–8.58)
25(OH)D (ng/mL) 0.90 (0.78–1.04)
Maternal ferritin (ng/mL) 1.01 (0.98–1.03)
CI, confidence interval; 25(OH)D, 25-hydroxyvitamin D. 
*P<0.05.
Table 4. Determinants of vitamin D deficiency in breastfed infants 
Variable Odds ratio (95% CI) 
Age (mo) 0.15* (0.02–0.97)
Birth weight (kg) 2.81 (0.18–44.38)
Body weight (kg) 0.73 (0.28–1.88)
Duration of breast feeding (mo) 6.12 (0.86–43.31)
Presence of iron deficiency 4.74 (0.36–62.43)
Maternal 25(OH)D (ng/mL) 0.74* (0.59–0.92)
CI, confidence interval; 25(OH)D, 25-hydroxyvitamin D.
*P<0.05.
y=1.02x–1.24 
r=0.54 
p<0.005 
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Fig. 1. The correlation between infant and maternal levels of 25- 
hydroxyvitamin D (25(OHD). 
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production of vitamin D.
The limitations of our study include its small number of sub­
jects and the fact that this is a hospital­based study with possible 
selection bias. In addition, there was a lack of maternal medical 
record information including details of the amount of bleeding 
and the time of cord clamping at delivery as well as the socioeco­
nomic data for our study group. There were also problems related 
to analyzing the ferritin level in infants who might have had in­
flammation without elevated CRP. Laboratory tests such as hep­
cidin, principal regulator of iron homeostasis to regulate iron 
transport across the gut mucosa, might be necessary in this 
situation35). 
In conclusion, the maternal prepregnancy iron status and 
current maternal vitamin D has an effect on vitamin D of their 
breastfed infants. The prevalence of ID in infants significantly 
increased with the duration of breast feeding. Therefore, it is 
needed to concern about vitamin D as well as iron in breastfed 
infants with maternal prepregnancy anemia. In addition, a 
prospective research with a large number of subjects is needed to 
clarify micronutrient needs in pregnancy and during lactation for 
breastfed infants.
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